Cover Story
Free
By Alice Tracey
After consulting with women in oncology, The Cancer Letter has created a guide to help whistleblowers think strategically as they report gender bias and confront institutional resistance.
In Brief
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for January 2022
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast